Navigation Links
Institut Pasteur Korea and Proteros establish a new collaboration
Date:5/24/2011

Martinsried, Germany, May 24, 2011. Proteros Biostructures GmbH (Proteros) announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K. Under this collaboration Proteros will apply its know-how, experience of structural analysis and its proprietary X-ray crystallography platform to support IP-K's mission to develop therapeutics for infectious diseases.

Cony D'Cruz, Chief Business Officer of Proteros, stated, "Institut Pasteur Korea is a world class translational research institute, renowned as a centre of excellence in biomedical research and technology development with a clear focus on infectious and neglected disease. We welcome the opportunity for Proteros to contribute to these efforts."

Dr. Michel Liuzzi, Director, Early Discovery Program at IP-K, added "We are very pleased with the expertise and know-how of Proteros in providing timely X-ray crystallography support to our in-house drug discovery projects and we look forward to continue collaborating with Proteros in the future."


'/>"/>

Contact: Jean Kim
publicrelations@ip-korea.org
82-318-018-8041
Institut Pasteur Korea
Source:Eurekalert

Page: 1

Related medicine news :

1. NIH awards Salk Institute $5.5 million grant to study Williams syndrome
2. CHEO Research Institute develops secure protocol for data disclosure
3. Weizmann Institute scientists show: How adversity dulls our perceptions
4. Cryoablation used to successfully treat atrial fibrillation at the Montreal Heart Institute
5. CIRM awards Scripps Research Institute scientists $3.5 million
6. Obesity: Conclusive results for the Montreal Heart Institutes EPIC Centre Kilo-Actif program
7. Group Health Research Institute founder Dr. Ed Wagner wins William B. Graham Prize
8. Duke Human Vaccine Institute signs research agreement to develop pandemic virus vaccines
9. ASH partners with AMEH and National Cancer Institute to improve diagnosis of leukemia in Mexico
10. Commentary: When creating a new institute, the devils in the details
11. Institute for Health Metrics and Evaluation to launch new Global Health Data Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2017)... ... ... Millions of families and businesses worldwide depend on high quality water from ... water. However, well water can also become contaminated with bacteria and odors from flood ... The EPA does not regulate private drinking water wells. Many states and towns do ...
(Date:9/24/2017)... ... ... boy was walking home and feeling down about himself. He didn’t think he was good ... he can do whatever he wants to do if he puts his mind to it. ... God created him with special talents and gifts. We see his internal dialogue change. He ...
(Date:9/24/2017)... ... ... The Other Sheep”: the ceremonial laws of Moses and the Holy Law of God reexamined. ... author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, but he ... Adventist Church for many years. He was previously a member of the Anglican Church ...
(Date:9/23/2017)... San Francisco, CA (PRWEB) , ... September 23, 2017 , ... ... Bay Area, is proud to announce a new blog post focused on the ARTAS® ... loss, they understandably hope to turn to the latest, most technologically sophisticated methods of ...
(Date:9/22/2017)... Albert Lea, MN (PRWEB) , ... September 22, 2017 , ... ... and video) at its rally to interview citizens on why they are rallying against ... stories and commitment to this effort against Dr. Noseworthy’s (CEO) decision to close the ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: